1-20 of 64
Keywords: Immunotherapy
Close
Follow your search
Access your saved searches in your account

Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2023) 101 (3): 159–165.
Published Online: 07 March 2023
..., instructions or products referred to in the content or advertisements. 2022 Hodgkin lymphoma Lymphoma Chemoimmunotherapy Systemic therapy Immunotherapy Decision-making Hodgkin lymphoma is a rare disease, affecting young adults and, in a second peak, patients over the age of 60 years. Among...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2023) 101 (5): 283–291.
Published Online: 19 January 2023
... Prognostic factor Immunotherapy Nutrition Hepatocellular carcinoma (HCC) remains the third leading cause of cancer death worldwide [ 1 ]. However, the therapeutic armamentarium available has expanded in recent years with the approval of new systemic treatments. Sorafenib was the only available...
Journal Articles
Journal Articles
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2022) 100 (5): 290–302.
Published Online: 29 March 2022
... nonampullary duodenal adenocarcinoma Microsatellite instability Prognosis Immunotherapy Small bowel adenocarcinoma (SBA) is rare compared with other gastrointestinal cancers, and primary small bowel malignancies are even rarer, accounting for less than 5% of all gastrointestinal tumors [1...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2021) 99 (5): 310–317.
Published Online: 09 March 2021
... office visit. Toxicities were graded based on National Cancer Institute Common Toxicity Criteria for Adverse Events (CTCAE) version 4.03 (2010). Fibrolamellar carcinoma 5-FU Interferon Nivolumab Immunotherapy With fewer than 200 new cases per year worldwide, fibrolamellar carcinoma (FLC...
Journal Articles
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2021) 99 (3): 192–202.
Published Online: 13 January 2021
... and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Renal cell carcinoma Nivolumab Immunotherapy Programmed cell death protein 1 inhibitor Immune checkpoint...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2020) 98 (11): 749–754.
Published Online: 14 July 2020
... as an intravenous formulation as well as an oral formulation, with response rates of 6–12% in chemorefractory disease and 15–37% in chemosensitive disease. Immunotherapy has recently been approved as a first-line agent in metastatic SCLC in combination with chemotherapy. It is also approved as a third-line agent...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2020) 98 (5): 303–310.
Published Online: 25 February 2020
...(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements. Immune exhaustion OX40 OX40 ligand Lung cancer Immunotherapy OX40, a member of the tumor necrosis factor...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2020) 98 (2): 123–130.
Published Online: 30 October 2019
..., is a clinical challenge. Baseline clinical factors such as asthma may portend the development of pneumonitis due to pre-existing airway inflammation prior to immunotherapy. Objective: The purpose of the study was to investigate whether a prior diagnosis of asthma is associated with an increased risk of immune...
Journal Articles
Subject Area:
Oncology
Journal: Oncology
Oncology (2019) 97 (6): 365–372.
Published Online: 18 September 2019
...Jumpei Kashima; Yusuke Okuma; Yukio Hosomi; Tsunekazu Hishima Introduction: Soluble CD27 (sCD27) is associated with somatic immune reaction status. Moreover, sCD27 level is associated with the prognosis of patients with prostate cancer who receive immunotherapy. Objective: In this study, we...
Journal Articles